Read untitled text version

WEDNESDAY, APRIL 16 / 4:00 P.M.­7:00 P.M FIRST AUTHORS STAND BY POSTER FROM 5:30 P.M.­7:00 P.M.

NEUROVIROLOGY: HIV P05.001 Prevalence and Risk Factors of HIV Encephalopathy in Adult Malawians Vishal N. Patel, Tapiwa F. Tarumbiswa, Randy G. Mungwira, Joep J. van Oosterhout P05.002 HIV-Associated Strokes in Minority Patients in an Inner City Teaching Hospital: Retrospective Data Analysis Dulara Hussain, Mansoor Nasim, Jhansi Gajjala, Che M. Harris, Shilpa Marwaha, Kelechi Chiori, Vinod R. Mody, Marlon G. Daniel P05.003 Gonadal Hormone Dysfunction and HIV-Associated Neurocognitive Disorders in Women Valerie Wojna, Thomas Curry, Richard Skolasky, Raul Mayo, Ola Selnes, Justin McArthur, Loyda Melendez, Mayra Fernandez, Carole Bryant, Avindra Nath P05.004 Cortical Direct Current Stimulation for the Treatment of Minor Depression in HIV-Positive Persons Donatello Arienzo, Pasquale Romeo, Fortunato Battaglia P05.005 Correlates of HIV Sensory Neuropathy in a Puerto Rican Cohort Marla Jordan-Gonzalez, Nivia HernandezRamos, Richard Skolasky, Tania Ginebra, Enid Castillo, Carlos A. Luciano P05.006 Peripheral Neuropathy in HIV Positive Zambian Adults Is Not Due to Micronutrient Deficiency or Derangements of Tryptophan Metabolism Masharip Atadzhanov, Poneh Adib-Samii, Dietmar Fuchs, Vera Yambayamba, Paul Kelly P05.007 Mitochondrial Oxidative Stress and Painful Peripheral Neuropathy in HIV Infection Aaron M. McMurtray, Diana Chen, Valcour Victor, Mariana Gerschenson, Cecilia Shikuma P05.008 NeuroIRIS in HIV Infection: Clinical and Epidemiological Aspects Jennifer A. McCombe, Roland Auer, Stan Houston, Michael J. Gill, Christopher Power P05.009 Modulation of In Vivo T Cell Activation by an AcetylcholineEsterase Inhibitor in Patients Chronically Infected with HIV Sergio Valdes-Ferrer, Jose C. Crispin, Pablo F. Belaunzaran, Alejandra Gonzalez-Duarte, Carlos Cantu-Brito P05.010 Determination of the Source of Increased Cerebrospinal Fluid Immunoglobulins in Human Immunodeficiency Virus Seropositive Patients Akintomi A. Olugbodi, Adeola O. Tomi-Olugbodi NEUROVIROLOGY P05.011 Transplant-Associated Transmission of West Nile Neuroinvasive Disease Kurt Lindsay, Robert Egan P05.012 Knowledge, Attitude and Perceptions about Tetanus and Rabies; a Population Based Survey from Karachi, Pakistan Abdul Malik, Mohammad Wasay, Adnan Yousuf, Rajesh Chawla, Haroon Daniel, Iqbal Azam P05.013 Progressive MRI Abnormalities in Human Rabies Encephalomyelitis Alan H.Yee, Ryan Merrell, Alexander T. Zubkov, Charles E. Rupprecht, Allen Aksamit, William Hu, Edward Manno P05.014 Dengue Fever as a Cause of Benign Acute Chilhood Viral Myositis Leonardo Halley C. Pimentel, Francisco de Assis A. Gondim, Gisele R. Oliveira, Francisco J. MontAlverne P05.015 Chikungunya Fever Epidemic in South India: Neurological Complications Jagarlapudi Muralikrishna Murthy, Jyoti Jawatkar, Amitav Rath, Guruprasad Hosurkar, Amrit Bhushan Saxena P05.016 Following the Stages of Herpes Simplex Virus Type 1 (HSV-1) Infection of Mice Brain in Organotypic Cultures Israel Steiner, Myetal Cohen, Efrat Braun, Tal Zimmerman, Amos Panet P05.017 A Binding Partner of L Protein of Theiler's Murine Encephalomyelitis Virus (TMEV) and Its Potential Role in Virus Persistence Yoshiro Ohara, Naoko Taniura, Takako Okuwa, Mineki Saito, Kousuke Saito, Kunihiko Asakura RETROVIRUSES AND OPPORTUNISTIC INFECTIONS P05.018 Neurological Impairment and Disability in HTLV-1 Associated Myelopathy Patients Francisco Javier Carod-Artal, Hudson Mourão Mesquita, Luciola Ribeiro, Wladimir Kummer, Cynthia Costa P05.019 Amyotrophic Lateral Sclerosis (ALS) Syndrome Associated to HTLV-I Virus Infection Soraya P. Da Silva, Fábio H. G. Porto, Marcos R. G. De Freitas, Osvaldo J. M. Do Nascimento, Ivan R. F. Da Silva, Marco A. Orsini, Ricardo L. Simões, Ana Carolina M. T. De Mattos, Fernando M. Cardoso P05.020 Pattern of CNS AIDS at the Fevers Unit, KBTH over 1 Year Albert K. Akpalu, Margaret Lartey P05.021 Immune Reconstitution Inflammatory Syndrome in a Patient with AIDS and Cerebral Toxoplasmosis: A Case Report John Maguire, Alister Prout, John Hooge, Gerald Pfeffer P05.022 Spinal Cord Toxoplasmosis as an Unusual Presentation for AIDS Diagnosis: Case Report and Review Carmen R. Fuentes, Carlos Garcia Gubern P05.023 Diagnosis and Outcome of Progressive Multifocal Leukoencephalopathy (PML) at an Urban Public Hospital Russell E. Bartt, Lauren Kanner, Uma Muppidi, Joseph J. Pulvirenti P05.024 Systemic Nocardiosis with Multiple Brain Abscesses in a Rheumatoid Arthritis Recipient Treated with TNF Blockers and Successfully Treated with Antibiotics Alone Lucien Rumbach, Eloi Magnin, Eric Berger, Sandra Mathieu, Francoise Cattin, Daniel Wendling NEURO-OPHTHALMOLOGY/ NEURO-OTOLOGY P05.025 Weight Gain and Recurrence in Idiopathic Intracranial Hypertension (IIH) Melissa Ko, Grant Liu, Joshua Ney, Nicholas Volpe, Steven Galetta, Laura Balcer P05.026 Rare Mitochondrial DNA Point Mutations Pathogenic for Leber Hereditary Optic Neuropathy Patrizia Amati-Bonneau, Pascal Reynier, Luisa Iommarini, Maria Lucia Valentino, Chiara La Morgia, Marzio Bellan, Helene Dollfus, Antoine Moulignier, Ghislaine Ducos, Christophe Orssaud, Alessandro Achilli, Anna Olivieri, Maria Pala, Antonio Torroni, Valerio Carelli P05.027 Familial Clustering in NonArteritic Anterior Ischemic Optic Neuropathy (NAION) William Hills, Bradley Katz, Judith Warner, Kang Zhang, Jennifer Harmon, Geraldine Mineau, Kathleen Digre P05.028 Visual Field Deficits Following Temporal Lobe Epilepsy Surgery: A Long Term Follow-Up and Prognostic Implications Debbie Yam, David Nicolle, Tiiu Hess, Jorge G. Burneo P05.029 Chronic Relapsing Inflammatory Optic Neuritis (CRION): Is It Neuromyelitis Optica? Jerome De Seze, Carl Arndt, Luc Jeanjean, Helene Zephir, Frederic Blanc, Pierre Labauge, Marie Bouyon, Laurent Ballonzoli, Marie Fleury, Patrick Vermersch, Claude Speeg P05.030 Purtscher's Retinopathy in a Postpartum Patient with Hypertensive Encephalopathy Dhimant L. Dani, Jordan G. Lubahn, Jarrod D. Dale, Roger N. Rosenberg, Olaf Stuve, Worthy R. Warnack P05.031 Retinal Nerve Fiber Layer Assessed by OCT in Different Forms of Multiple Sclerosis Claire Meyniel, Vivien Vasseur, Olivier Gout P05.032 Cortical Blindness Following Fludarabine Therapy: A Case Report and Review of Literature Ashok Verma, Natalia Llanes, David Rose, Arish Edulzee P05.033 Retrospective Evaluation of Optic Neuritis in African American Patients Matthew C. Sniegowski, Gregory VanStavern P05.034 Optical Coherence Tomography in Neuromyelitis Optica Jerome De Seze, Frederic Blanc, Luc Jeanjean, Helene Zephir, Pierre Labauge, Marie Bouyon, Laurent Ballonzoli, Giovanni Castelnovo, Marie Fleury, Sabine Defoort, Claude Speeg, Patrick Vermersch P05.035 Epley's Manoeuvre for Benign Paroxysmal Positional Vertigo: A Prospective Study Ignacio Casanova, Jesús Porta-Etessam, Rocio Garcia-Cobos, Teresa Lapeña, Ana Escribano, German Latorre, Carlos Lopez de Silanes P05.036 Topiramate in Patients with Migraine Associated Recurrent Vertigo Jesús Porta-Etessam, Germán Latorre, Ana Escribano, Carlos Lopez de Silanes, Rocío Garcia-Ramos, María José Fernandez P05.037 Novel Role of Greater Occipital Nerve Trigger Point Injections in a Sub-Set of Tinnitus Patients Neil Cherian, Eric Baron P05.038 Unnecessary High Costs in the Evaluation of Benign Paroxysmal Positional Vertigo Sharon Hartman Polensek, Ronald Tusa P05.039 Chronic Tinnitus: A Neurological Problem Anna Piera, Miguel J. A. Láinez, Carlos De Paula, César Avila, Salvador Campos P05.040 Neuro-Otologic Abnormalities in Patients with Fabry Disease Sergio Carmona, Ana Pardal, Cintia Marchesoni, Natalia Salvatico, Ricardo Reisin, Carlos Romero, Francisco Meli, Gustavo Sevlever, Paulina Yañez, Silvia Vazquez, Guillermo Caceres P05.041 Combined Horizontal and Vertical One-and-A-Half Syndrome (OAHS) Due to Antiphospholipid Syndrome Michael H. Pfeiffer, Laxman B. Bahroo, Carlo Tornatore P05.042 Neuro-Ophthalmic Findings That May Reliably Differentiate Progressive Supranuclear Palsy and Parkinson's Disease William L. Hills, Judith Warner, Bradley Katz, Gordon Chelune, Norman Foster, John Steffens, Perla Thulin, Steven Chin, Kathleen Digre P05.043 Ocular Motor Anatomy in Interrupted Saccades Janet Rucker, R. Leigh, Lance Optican, Edward Keller, Jean Buettner-Ennever

POSTER SESSION V

65

POSTER SESSION V

P05.044 Is IGT a Risk Factor for Idiopathic Ophthalmoplegia? Akira Machida, Taiji Tsunemi, Kinya Ishikawa, Yokota Takanori, Hidehiro Mizusawa P05.045 MRI Volumetric Studies of Cerebellar Atrophy in Late-Onset TaySachs Disease (LOTS) Willa F. Moore, Barbara E. Shapiro, R. John Leigh, Sarah H.Ying MULTIPLE SCLEROSIS AND RELATED DISEASES: OPTICAL COHERENCE TOMOGRAPHY P05.046 Quadrant-Specific Retinal Nerve Fiber Layer Thinning by Optical Coherence Tomography (OCT) in MS Deepika Nemani, Maulik Zaveri, Amy Conger, Amber Salter, Teresa Frohman, Steven Galetta, Clyde Markowitz, Dina Jacobs, Gary Cutter, Gui-Shuang Ying, Maureen Maguire, Peter Calabresi, Elliot Frohman, Laura Balcer P05.047 Retinal Nerve Fibre Layer Axonal Loss Following Unilateral Acute Optic Neuritis Andrew Henderson, Anand Trip, Patricio Schlottmann, Daniel Altmann, David Garway-Heath, Gordon Plant, David Miller P05.048 Diffusion Tensor MRI and Optical Coherence Tomography as Measures of Anterior Visual Pathway Integrity in MS Robert A. Bermel, Natasha Frost, Mark J. Lowe, Ken A. Sakaie, Jian Lin, Jerome Ramos-Esteban, Scott Smith, Micheal D. Phillips, Jeffrey Cohen P05.049 Retinal Nerve Fiber Layer Thickness Is Associated with Proton Magnetic Resonance Spectroscopy Measures and Brain Atrophy in Multiple Sclerosis Malgorzata Siger, Krzysztof Dziegielewski, Lukasz Jasek, Marek Bieniek, Agnieszka Nicpan, Jerzy Nawrocki, Krzysztof Selmaj P05.050 Does Chronic Optic Neuritis Exist in Multiple Sclerosis? Charlotte Crinquette, Ha-Chau Tran, Alexandre Mackowiak, Patrick Hautecoeur P05.051 Retinal Atrophy Using Optical Coherence Tomography in 94 Patients with Multiple Sclerosis and Comparison with Healthy Subjects Luc Jeanjean, Giovanni Castelnovo, Marie Bouyon, Philippe-Jean Bousquet, Gerard Dupeyron, Jerome De Seze, Pierre M. Labauge

WEDNESDAY, APRIL 16 / 4:00 P.M.­7:00 P.M. FIRST AUTHORS STAND BY POSTER FROM 5:30 P.M.­7:00 P.M.

MULTIPLE SCLEROSIS AND RELATED DISEASES: NEUROMYELITIS OPTICA AND RELATED DISORDERS P05.052 Neuromyelitis Optica Treated with Mycophenolate: Retrospective Analysis of 25 Cases Anu Jacob, Brian Weinshenker, Marcelo Matiello, Dean Wingerchuk, Elizabeth Schuster, Jonathan Carter, Mark Keegan, Orhun Kantarci, Claudia Lucchinetti, Sean Pittock P05.053 Is Neuromyelitis Optica Associated with HLA? Helene Zéphir, Isabelle Fajardy, Olivier Outteryck, Frédéric Blanc, Laurent Castera, Marie Fleury, G. Rudolf, Romain Marignier, Sandra Vukusic, Christian Confavreux, Patrick Vermersch, Jerome De Seze P05.054 Familial Neuromyelitis Optica Marcelo Matiello, Doralina G. Brum, Amilton Barreira, Daniel Kingsbury, Brian Weinshenker P05.055 Sjögren Myelopathy and Neuromyelitis Optica Sung-Min Kim, Su-Yeon Kim, Jung-Joon Sung, Patrick Waters, Angela Vincent, Kwang-Woo Lee P05.056 Distinct Immunological Features Compared between AntiAquaporin-4 Antibody-Positive and -Negative Opticospinal Japanese Multiple Sclerosis Patients Takuya Matsushita, Takeshi Matsuoka,Yuji Kawano, Nan Shi, Jun-ichi Kira P05.057 Devic's Neuromyelitis Optica: An Analysis of 47 Patients and Prognostic Implications of NMO IgG Status Gulsen Akman-Demir, Mefkure Eraksoy, Erdem Tuzun, Sven Jarius, Sema Icoz, Murat Kurtuncu, Paddy Waters, Zuhal Yapici, Melike Mutlu, Angela Vincent P05.058 A Western Blot and Immunoprecipitation Method To Detect Anti-NMO IgG and AntiAQP4 Antibodies in the Serum of Patients with Neuromyelitis Optica Antonio Bertolotto, Fabiana Marnetto, Bianca Hellias, Paola Valentino, Marco Capobianco, Simona Malucchi, Alessia Di Sapio, Letizia Granieri, Marzia Caldano, Francesca Gilli, Arianna Sala P05.059 Fatigue Is Less Prominent in Neuromyelitis Optica Than in Multiple Sclerosis: Pathophysiological Implications Dean Wingerchuk, Jonathan Carter P05.060 Spinal Stenosis Leads to Misdiagnosis of Transverse Myelitis Brendan Kelley, Brian Weinshenker P05.061 Neuromyelitis Optica and Celiac Disease Roberto Bergamaschi, Paola Crivelli, Micaela Robotti, Alessandra Persico, Diego Franciotta, Stefano Bastianello, Vittorio Cosi P05.062 Brain Abnormalities of Neuromyelitis Optica in China Qi Li, Peng Xie,Yongmei Li, Xinyue Qin, Fajin Lv P05.063 Blood Brain Barrier (BBB) Impairment in NMO-IgG Seropositive Patients: An Aquaporine-4 (AQP-4) Related Damage? Carla Tortorella, Maddalena Ruggieri, Giovanni Bosco Zimatore, Antonio Frigeri, Anna Lia, Elisabetta Di Monte, Angelo Ghezzi, A. Rizzo, Maria Amato, Bahia Hakiki, Francesco Patti, Alessandra Lugaresi, Elisa Merelli, Paolo Livrea, Maria Svelto, Maria Trojano P05.064 Development of Extensive Brain Lesions Following Interferon-beta Therapy in Relapsing Neuromyelitis Optica and Longitudinally Extensive Myelitis with Anti-Aquaporin-4 Antibody Yuko Shimizu, Kazumasa Yokoyama, Tatsuro Misu, Kazuo Fujihara,Yoshiyuki Takahashi, Seiji Kikichi,Yasuto Itoyama, Makoto Iwata MULTIPLE SCLEROSIS AND RELATED DISEASES: OUTCOMES AND SCALES II P05.065 Impact of Natalizumab on Multiple Sclerosis Patient-Reported Experiences: A Cross Sectional Survey Judith J. Stephenson, Kitty Rajagopalan, Siddhesh A. Kamat, Brian Prunier P05.066 The Optometric Correlates of Multiple Sclerosis Ben Newman Wright, Arnold J. Wilkins,Yannis Zoukos, Thomas Thomaides P05.067 A New Severity-Based Classification System for Multiple Sclerosis Joseph Herbert P05.068 Cognitive Presentation in Multiple Sclerosis (MS) Rana Assouad, Ayman Tourbah, Caroline Papeix, Frederic Sedel, Maia Tchikviladze, Serge Mrejen, Nina Benoit, Irene Coman, Damien Galanaud, Stephane Lehericy, Bertrand Fontaine, Olivier Lyon-Caen, Catherine Lubetzki, Bruno Stankoff P05.069 Multiple Sclerosis ­ Effects of Immunomodulatory Therapy on Pregnancy Outcome ­ A Clinical Study ­ Preliminary Results Kerstin Hellwig, Corinna Weber Schoendorf, Ralf Gold, Christof Schaefer P05.070 The Modified Rankin Score, EDSS and MRI Measures Using CombiRx Baseline Assessments Robin Conwit, Stacey S. Cofield, Gary R. Cutter, Jerry Wolinsky, Fred Lublin P05.071 Resistance Training Reduces Fatigue and Depression in Patients with Multiple Sclerosis ­ Preliminary Data from an Ongoing Study Ulrik Dalgas, Egon Stenager, Thor Petersen, Hans J. Hansen, Johannes Jakobsen, Kristian Overgaard, Caroline Knudsen, Thorsten Ingemann-Hansen P05.072 Quality of Life in Patients with Multiple Sclerosis: The Impact of Cognitive Deficit and Fatigue Jarmila Szilasiova, Zuzana Novosadova, Zuzana Gdovinova P05.073 Does Adherence to Disease Modifying Agents Influence Quality of Life in Patients with Multiple Sclerosis? Mirela Cerghet, Jennifer Elston-Lafata, Lonni Schultz, Stanton Elias, Elizabeth Dobie, Kaan Tunceli, Jackqueline Reuther P05.074 Robot Training Protocol for Cerebellar Multiple Sclerosis Subjects: A Double Blind Randomised CrossOver Study Claudio Solaro, Giampaolo Brichetto, Elena Vergaro, Valentina Squeri, Maura Casadio, Antonio Uccelli, Vittorio Sanguineti P05.075 Association between Treatment Compliance and Severe Relapses for Multiple Sclerosis Patients Receiving Disease-Modifying Drugs: Findings from a National Managed Care Database Dennis M. Meletiche, Chris Kozma, Randy Bennett, Ahmad Al-Sabbagh P05.076 Examination of Quality of Life in RRMS Patients during the First Year of Treatment with Interferon beta-1a (IM) Norman Putzki, Petra Schicklmaier, Gabriele Niemczyk, Hans Hartung, "Mensch im Mittelpunkt" Study Group P05.077 Regression Modeling of T2 Lesion Volume in Patients with a Clinically Isolated Syndrome at High Risk ­ A Pooled Data Analysis Anneke Neuhaus, Martina Güntner, Sean P. Morrissey MULTIPLE SCLEROSIS AND RELATED DISEASES: NEUTRALIZING ANTIBODIES P05.078 Characterization of the Affinity Maturation of the Immune Response Against IFNb Using Surface Plasmon Resonance (BiacoreTM) Ebrima Gibbs, Regina Lam, Joel Oger P05.079 The Cross-Reactivity of the Neutralizing Antibodies (NAbs) to the Different Interferons (IFN) Used To Treat Multiple Sclerosis Is Very Far from Complete and This Has Major Clinical Relevance for Defining Positivity and "High Titers" Joel Oger, Regina Lam, Ebrima Gibbs P05.080 Validation of a Luciferase Reporter Gene Assay Against the Standard Cytopathic Effect Assay (CPE) for Neutralizing Antibodies (NAbs) to Interferon Beta (IFN-B) in IFN-B Treated Multiple Sclerosis Patients Regina Lam, Tariq Aziz, Ebrima Gibbs, Sidney Grossberg, Joel Oger

66

WEDNESDAY, APRIL 16 / 4:00 P.M.­7:00 P.M MCCORMICK PLACE WEST CONVENTION CENTER / EXHIBITION HALL

P05.081 High Dose Intravenous Interferon-beta in MS Patients with Neutralizing Antibodies (HINABS) ­ A Pilot Study Florian Deisenhammer, Alban Millonig, Claudia Gneiss, Markus Reindl, Thomas Berger P05.082 Evaluation of 4 Different Assays To Determine Antibodies to Interferon-beta Bernhard Hemmer, Til Menge, Gloria Von Geldern, Sonja Hochgesand, Hans Hartung, Florian Deisenhammer P05.083 An Association between Serum Apolipoprotein E Levels and Anti-Interferon- Neutralizing Antibodies in Multiple Sclerosis Armando Sena, Rui Pedrosa, Maria J. Cascais, Firmina Lebre, Maria L. Andrade, Veronique Ferret-Sena, Maria G. Morais P05.084 Incidence of Binding and Neutralizing Antibodies in Sera and Cerebrospinal Fluid of Patients with Relapsing-Remitting Multiple Sclerosis Treated with Interferon Beta Andres Villa, Cristina Videla, Carmen Ricarte, Orlando Garcea, Raul Piedrabuena, Fernando Caceres, Roberto Rey, Guadalupe Carballal MULTIPLE SCLEROSIS AND RELATED DISEASES: NEUROPATHOLOGY AND NEUROPHYSIOLOGY P05.085 Clinico-Pathological Correlations of Perivenous Versus Confluent Demyelination in Acute Inflammatory Demyelinating Disease Nathan Young, Shanu Roemer, Joseph Parisi, Brian Weinshenker, Claudia Lucchinetti P05.086 EEG Abnormalities in Patients with Multiple Sclerosis Lisa M. Bateman, Mark Agius, Masud Seyal P05.087 Evidence for Small Fiber Neuropathy in Multiple Sclerosis Kristina Gartzen, Norman Putzki, Zaza Katzarava P05.088 Mitochondrial DNA Deletions Accumulate in the Brain Related to Aging but Not to the Pathology of Multiple Sclerosis Bernadette Kalman, Andrei Blokhin, Tamara Vyshkina P05.089 Dermatomal Somatosensory Evoked Potentials (DSEPs) Can Identify Lumbosacral Spinal Stenosis (LSSS) in Patients with Multiple Sclerosis (MS) Angeli S. Mayadev, Michele Furman, George Kraft P05.090 Lhermitte's Sign in Multiple Sclerosis: Neuroradiological Correlation Egemen Idiman, Serkan Ozakbas, Derya Kaya, Ozan Sagut, Ozlem Sahin, Esra Coskuner Poyraz AGING AND DEMENTIA: PATHOLOGY P05.091 The Neuroanatomical Correlates of Abnormal Behavior in Frontotemporal Dementia Giovanna Zamboni, Edward D. Huey, Frank Krueger, Paolo F. Nichelli, Jordan Grafman P05.092 Progranulin Capillary Length-Density Is Reduced in Alzheimer's Disease (AD) Hippocampus: A Role for Aberrant Wound Healing and Angiogenesis in the Pathogenesis of AD Rahmeen Farhoudi, Ela Patel, Stephen W. Scheff, William Markesbery, Gregory Jicha P05.093 Spongiform Change in Lewy Body Dementia and Alzheimer's Disease Abdullah Sherzai, Steven D. Edland, Eliezer Masliah, Lawrence Hansen, Donald P. Pizzo, Ayesha Z. Sherzai, Jody Corey-Bloom P05.094 Clinicopathological Case Comparison: Familial Frontotemporal Lobar Degeneration-Motor Neuron Disease with Phenotypic Heterogeneity in Two First-Degree Relatives Keith Vossel, Katya Rascovsky, Richard Crawford, Gil Rabinovici, Bruce Miller, Stephen DeArmond, William Seeley P05.095 An Extended Analysis of the Histological Variants of Tau-Negative Frontotemporal Lobar Degeneration Keith Josephs, Alex Stroh, Catalina Amador-Ortiz, Neill Graff-Radford, Dennis Dickson P05.096 An Association between Lewy Body Pathology and Cerebral Atherosclerosis Lawrence S. Honig, Karen Marder, Jean Paul G. Vonsattel, Nikolaos Scarmeas P05.097 Dementia with Lewy Bodies (DLB), Parkinson's Disease Dementia (PDD) and Alzheimer Dementia (AD): A Retrospective Clinical Comparison and Quantitative Neuropathologic Study Avi A. Algom, Dennis M. D. Dickson P05.098 Effect of Age on the Distribution of Tau Immunoreactivity in Alzheimer's Disease Nadia Laksiri, Andre Maues De Paula, Elsa Kaphan, Jean-François Pellissier, Olivier Felician, Mathieu Ceccaldi P05.099 Postmortem Stability of Alzheimer's Disease-Associated Proteins Randall L. Woltjer, Joseph Quinn, Jeffrey Kaye P05.100 Butyrylcholinesterase (BuChE) Expression as a Marker of Endangerment of Cortical Neurons in Early Alzheimer's Disease (AD) Juan Troncoso, Vassilis E. Koliatsos AGING AND DEMENTIA: OTHER P05.101 A Plasma Panel of Nutrient Biomarkers Is More Reliable Than Food Frequency Questionnaire in MCI Subjects Gene L. Bowman, Jennifer R. Baxter, Barry Oken, Balz Frei, Maret Traber, Jeffrey Kaye, Scott Leonard, Jackilen Shannon, Joseph Quinn P05.102 Degraded Temporal Integration in the Aging Primary Auditory Cortex Etienne De VillersSidani, Michael Merzenich P05.103 Diet, Exercise and Alzheimer's Disease Risk Nikolaos Scarmeas,Yaakov Stern, Nicole Schupf, Jose Luchsinger AGING AND DEMENTIA: COGNITION P05.104 Cognitive Reserve Mediates Amyloid-Related Cognitive Impairment Dorene M. Rentz, John Becker, Joseph Locascio, Erin Moran, Elisha Eng, Stephen Gomperts, Alan Fischman, Reisa Sperling, Keith Johnson P05.105 Endogenous Sex Hormones, Testosterone, Dehydroepiandrosterone-Sulfate (DHEAS) and Estradiol, and Cognition: Results from the Einstein Aging Study Rachel Saunders-Pullman, Mindy Katz, Molly Zimmerman, Nanette Santoro, Daniel McConnell, Gohar Zeitlian, Daniel Baseley, Kaili Stanley, Richard Lipton, Carol Derby P05.106 Cognitive Correlates of Poor Navigation in Cognitively-Normal Older Adults Amy E. Sanders, Richard Lipton, Roee Holtzer, Joe Verghese P05.107 A Comparison of Cognitive Reserve Markers for Predicting Rates of Memory Decline in Preclinical Alzheimer's Disease Charles Hall, Carol Derby, Joe Verghese, Molly Zimmerman, Mindy Katz, Herman Buschke, Richard Lipton P05.108 Assessment of Autobiographical Memory in Mild Cognitive Impairment Eve Tramoni, Marion Chaigneau, Michèle Balzamo, Olivier Felician, Mathieu Ceccaldi P05.109 Components of Episodic Memory: Relationship to Cognitive Decline and Cognitive Reserve Dan Mungas, Bruce Reed, Sarah Farias, Charles DeCarli P05.110 Non-Verbal Memory Performance Is Associated with Conversion to Dementia within 1 Year: A Prospective Study of MCI Using Computerized Cognitive Assessment Ely Simon, Tzvi Dwolatzky, Felicia Goldstein, Glen M. Doniger, Allan Levey, James Lah, Michael D. Friger P05.111 Context Processing and Stroop Deficits in Normal Aging Are Explained by White Matter Hyperintensities Adriane B. V. Mayda, Charles DeCarli P05.112 Performance on an Alzheimer-Selective Odor Identification Test in Patients with Parkinson Disease Robert Moore, Satyanarayana Gedela, Stephanie Studenski, Nicolaas Bohnen P05.113 Memory Performance Is Related to Amyloid and Tau Pathology in the Hippocampus Christiane Reitz, Lawrence Honig, Ming Xin Tang, Jean Paul Vonsattel, Richard Mayeux P05.114 Cued and Free Recall Verbal Memory Low Performance Predicts Dementia in the 3C Population-Based Study Sophie Auriacombe, Catherine Helmer, Hélène Amieva, Mélanie Le Goff, Jean-François Dartigues P05.115 A Comparison of Cognitive Structure in Healthy Controls, Parkinson Disease with and without Dementia and Alzheimer Disease David K. Johnson, John Morris, James Galvin P05.116 Clock Drawing: Quantitative and Qualitative Analysis of 131 AD Subjects Catherine Larochelle, Celine Chayer, Morris Freedman P05.117 RAVLT as an Instrument for the Early Diagnosis of Alzheimer Disease Amos Korczyn,Yohai Zeidman, Avraham Schweiger, Veronika Vachapov, Rut Verchovsky, Ilan Halperin, Miri Neufeld, Itzhak Fried, Fani Andelman P05.118 Fear Conditioning in Frontotemporal Lobar Degeneration and Alzheimer's Disease Howard Rosen P05.119 Apolipoprotein E and Cognitive Systems in Older Blacks and Whites Lisa L. Barnes, Zoe Arvanitakis, Robert Wilson, David Bennett P05.120 A Randomized Controlled Trial of Clock Drawing Test Scoring by Behavioral Neurologists Anil Nair, Moniek Damman, Welmoed Dekker, Robert Green, Emily Hubbard, Eric Steinberg, Alan Mandell, Sanford Auerbach, Robert Stern P05.121 Longitudinal Analyses of Cognition in Dementia of the Alzheimer Type, Parkinson's Patients with and without Dementia, and Healthy Controls David K. Johnson, John Morris, James Galvin P05.122 Frontal Systems Behavior Scale in Dementia Syndromes John D. Papatriantafyllou, Chrysanthos Mpoulas, Evi Likou, Lina Hatziantoniou, Panagiotis Zikos, Clementene E. Karageorgiou

POSTER SESSION V

67

POSTER SESSION V

P05.123 Cognitive Function Assessment in Normal Brazilian Elders: Different Profile Results Regarding to Age and Higher Educational Level Jeanette I. S. Farina, Silvana T. DalPonte, Maira R. Olchick, Nicole M. Steibel BEHAVIORAL NEUROLOGY: MEMORY AND DEMENTIA P05.124 Anatomy, Neuropsychology, and Behavior in a Series of 14 Autopsy-Proven Corticobasal Degeneration Patients Mary Catherine Mayo, William W. Seeley, Maria Gorno Tempini, Bruce L. Miller, Katherine P. Rankin P05.125 Mild Behavioural Impairment (MBI) and Risk of Dementia Fernando E. Taragano, Ricardo Allegri, Hugo Krupitzki, Diego Sarasola, Cecilia M. Serrano, Costantine Lyketsos P05.126 Fenofibrate Has a Disease Modifier Effect in the MPTP Mouse Model of Parkinson's Disease Alexandre Kreisler, Alain Duhamel, Alain Destée, Régis Bordet P05.127 Risk Factors for Transitions from Mild Cognitive Impairment to Dementia: Evidence from Cognitive Reserve Ricardo Allegri, Fernando E. Taragano, Hugo Krupitzki, Cecilia M. Serrano, Leandro N. Loñ, Diego Sarasola, Carol Dillon P05.128 Normative Data for the Montreal Cognitive Assessment (MoCA) in Young Adults Thomas L. Ratchford, Manuela Ochoa, Glen Finney P05.129 Validity and Reliability of the SF-36 Administered to Caregivers of Patients with Alzheimer's Disease Cecilia M. Serrano, Cristina G. Ranalli, Carol Dillon, Diego Sarasola, Galeno Rojas, Leonardo C. Bartoloni, Fernando E. Taragano, Gerardo Machnicki, Ricardo F. Allegri P05.130 Elucidating the Organizational Structure of Scripts ­ Evidence from Frontotemporal Dementia Christine Farag, Vanessa Troiani, Murray Grossman P05.131 Memory Impairment Screen (MIS) Normative Data and Discriminative Validity: Argentine Version Galeno J. Rojas, Leonardo C. Bartoloni, Carol Dillon, Cecilia M. Serrano, Leandro Loñ, Cristina G. Ranalli, Ricardo Allegri P05.132 The Relationship between Physical Performance and Cognitive Status in Lewy Body Dementia Gulden Akdal, Birgul Donmez, Görsev Yener P05.133 Prevalence of Cobalamin (Vitamin B12) Deficiency in a Demented Population Melissa Armstrong, Sudha Gupta

WEDNESDAY, APRIL 16 / 4:00 P.M.­7:00 P.M. FIRST AUTHORS STAND BY POSTER FROM 5:30 P.M.­7:00 P.M.

PARKINSON'S DISEASE: NONMOTOR MANIFESTATIONS P05.134 A Double-Blind, PlaceboControlled, Dose-Escalation Trial of Pimavanserin in Parkinson's Disease and Psychosis Stephen Revell, Joseph Friedman, Roger G. Mills, Hilde Williams, Ann D. Johnson, Daun Bahr P05.135 Cerebral Glucose Metabolic Changes in Parkinson Disease Patients with Visual Hallucinations Hee Kyung Park, Sun J. Chung, Jae Seung Kim, Ki Chun Im, Mi Jung Kim, Jae-Hong Lee, Myoung C. Lee P05.136 A Questionnaire-Based (UM-PDHQ) Study of Hallucinations in Parkinson's Disease Spiridon Papapetropoulos, Heather Katzen, Anette Schrag, Carlos Singer, Blake Scanlon, Daniel Nation, Alexandra Guevara, Bonnie Levin P05.137 Cingulate Atrophy Predicts Mild Cognitive Impairment in Early Parkinson Disease. A Voxel Based Morphometry Study Turi O. Dalaker, Robert Zivadinov, Jan P. Larsen, Mona Beyer, Jennifer Cox, Guido Alves, Kolbjorn Bronnick, Ole-Bjorn Tysnes, Ronald Antulov, Dag Aarsland P05.138 Hippocampal Atrophy in Parkinson's Disease Patients with Mild Cognitive Impairment Liana Apostolova, Mona K. Beyer, Amity E. Green, Christina Avedissian, Kristy Hwang, Dag Aarsland, Carmen C. Janvin, Jan P. Larsen, Jeffrey Cummings, Paul M. Thompson P05.139 The Relationship between Cognitive Functioning and Whole Brain Diffusion Tensor Imaging Abnormalities in Parkinson's Disease Michele York, Christof Karmonik, Elisabeth Wilde, Robert Grossman P05.140 The Relationship between Diffusion Tensor Tractography and Cognitive Functioning in Parkinson's Disease Michele York, Christof Karmonik, Ragani Yallampalli, Zili Chu, Robert Grossman, Elisabeth Wilde P05.141 Does Laterality of Motor Impairment Tell Us Something about Cognition in Parkinson Disease? Christine Cooper, Ania Mikos, Mary Wood, Lindsey Kirsch, Charles Jacobson, Michael Okun, Ramon Rodriguez, Dawn Bowers, Hubert Fernandez P05.142 A Comparison of Two Brief Cognitive Screening Instruments in Parkinson's Disease (PD) Stephanie L. Lessig, Matthew L. Ho, Mark W. Jacobson, Guerry Peavy, Jody Goldstein, Ryan Kim, Karen Wetzel, Deborah Fontaine, Jody Corey-Bloom P05.143 Non-Specific Motor and Cognitive Changes in Incidental Lewy Body Disease Charles Adler, Donald Connor, Marwan Sabbagh, John Caviness, Holly Shill, Joseph Hentz, Thomas Beach P05.144 Detecting Depression in Parkinson's Disease: How Useful Is the Unified Parkinson Disease Rating Scale? Irene A. Malaty, Benzi Kluger, Charles Jacobson, Michael Okun, Hubert Fernandez P05.145 PRODEST ­ Depressive Symptoms in Parkinson's Disease: Effect of Antidepressant Treatment on Symptom Items of Depression Paolo Barone, Christopher Goetz, John J. Houben, Juergen Koester, Albert F. Leentjens, Werner Poewe, Olivier Rascol, Heinz Reichmann, Anthony Schapira, Eduardo Tolosa P05.146 What Determines Resilience in Patients with Parkinson's Disease? Bradley J. Robottom, Karen Anderson, Roger J. Mullins, Amy Tai, Ann GruberBaldini, Paul Fishman, Stephen Reich, William Weiner, Lisa Shulman P05.147 Decision-Making Profile of Parkinson's Disease Patients with Pathological Gambling Malco D. Rossi, Eliana Roldan Gerschcovich, Delfina De Achaval, Daniel Cerquetti, Alejandra Amengual, Maria Ines Nouzeilles, Santiago Perez Lloret, Rodolfo Fahrer, Marcelo Merello, Ramon Leiguarda P05.148 Acamprosate Improves Impulse Control Disorders in Parkinson's Disease Joohi Shahed, Christine Hunter, Joseph Jankovic P05.149 Topiramate in Managing Impulse Control Disorders in Parkinson's Disease Pedro E. Bermejo, Cristina Ruiz-Huete, Buenaventura Anciones P05.150 Craving for Sweets and Other Compulsive Behaviors in Patients with Parkinson's Disease Joohi Shahed, Krystin Calhoun, Anthony Davidson, Joseph Jankovic P05.151 Mild Parkinsonian Signs Are Associated with Lower Olfactory Test Scores in the Community-Dwelling Elderly Elan Louis, Karen Marder, Matthias H. Tabert, D. P. Devanand P05.152 Subjective Assessments Do Not Adequately Evaluate Excessive Daytime Sleepiness in Parkinson's Disease Cynthia L. Comella, Ilia Itin, Margaret Park, Suzanne Stevens, Jean Jaglin, Wenqing Fan P05.153 Unique Relationship between Apathy and P3 Response in Parkinson's Disease David A. S. Kaufman, William M. Perlstein, Michelle J. Blanco, Michael J. Larson, Michael Okun, Hubert Fernandez, Dawn Bowers MOVEMENT DISORDERS: BOTULINUM TOXIN P05.154 Optimizing Algorithms To Identify Idiopathic Parkinson's Disease Cases within an Administrative Database Nicholas R. Szumski, Stefanie D. Vassar, Eric M. Cheng P05.155 Botulinum Toxin Type B Clinical Safety in Cervical Dystonia Following up to 4 Years of Treatment William Birmingham, Eric Pappert, Edgar Salazar-Grueso P05.156 Accelerometry: Variable Correlation with Functional Impact of Tremor Kelly Sullivan, Christopher Ward, Robert Hauser, Joseph Staffetti, Juan Sanchez-Ramos, Theresa Zesiewicz P05.157 Cardiovascular Fitness and Cognition in Mild-Moderate Parkinson's Disease Ergun Uc, Kevin Doerschug, Sonya Mehta, Matthew Rizzo, Kirk Erickson, Warren Darling, Steven Anderson, Robert Rodnitzky, Joel Kline, Arthur Kramer, Thomas Grabowski P05.158 Palatal Myoclonus: Three Key Points That Alert to Its Diagnosis Jose L. Ruiz-Sandoval, Carolina LeónJiménez, Erwin Chiquete, Carmen RuizSandoval, Miguel Andrade-Ramos P05.159 Tic Disorders in Musicians Richard J. Lederman P05.160 Botulinum Toxin Type B (MYOBLOC) in Patients with Cervical Dystonia: An Open-Label Extension Study (AN072-402 EU/CD) Joaquim J. Ferreira, Austen Moore, Eric Pappert P05.161 The G2019S LRRK2 Mutation in a Brazilian Cohort with Parkinson's Disease: Phenotype in Monozygotic Twins Renato Munhoz, Helio Teive, Lineu Werneck, Salmo Raskin, Christine Sato, Danielle Moreno, Ekaterina Rogaeva RESTLESS LEGS SYNDROME P05.162 Objective Assessment of Efficacy and Safety in Idiopathic RLS: Results from a 7-Week Sleep Lab Trial with the Transdermal Rotigotine Patch Wolfgang Oertel, Heike H. Benes, Luigi Ferini-Strambi, Diego Garcia-Borreguero, Birgit Hoegl, Ralf Kohnen, Joerg W. Keffel, Erwin Schollmayer, Karin Stiasny, Claudia Trenkwalder P05.163 Excessive Daytime Sleepiness in Idiopathic Restless Legs Syndrome: Characteristics and Evolution under Dopaminergic Treatment Ulf Kallweit, Massimiliano Siccoli, Esther Werth, Rositsa Poryazova, Claudio Bassetti

68

WEDNESDAY, APRIL 16 / 4:00 P.M.­7:00 P.M MCCORMICK PLACE WEST CONVENTION CENTER / EXHIBITION HALL

P05.164 Rapid Onset and Sustained Efficacy of Pramipexole in Restless Legs Syndrome Luigi Ferini-Strambi, Dagfinn Aarskog, Ray Chaudhuri, Markku Partinen, Mandy Sohr, Daniela Verri P05.165 Effects of Pramipexole on Daytime Symptoms of Restless Legs Syndrome Markku Partinen, Luigi FeriniStrambi, Dagfinn Aarskog, Ray Chaudhuri, Mandy Sohr, Daniela Verri P05.166 Rapid Onset of Action and Sustained Efficacy of Pramipexole in RLS Patients with Mood Disturbance Pasquale Montagna, Magdolna Hornyak, Jan Ulfberg, Seung Hong, Juergen Koester, Giovanni Crespi P05.167 Treatment of Daytime RLS Symptoms with Pramipexole in Patients with Mood Disturbance Magdolna Hornyak, Pasquale Montagna, Jan Ulfberg, Seung Hong, Juergen Koester, Giovanni Crespi P05.168 Effect of Food on the Clinical Pharmacokinetics of XP13512 Kenneth C. Cundy, Ritu Lal, Juthamas Sukbuntherng, Wendy Luo, Jacob Huff P05.169 Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin Kenneth C. Cundy, Srikonda Sastry, Wendy Luo, Joan Zou, Tristen Moors, Daniel Canafax P05.170 The Association between Acute Cerebral Infarction and Restless Legs James D. Geyer, Paul R. Carney, Stephenie C. Dillard, Camilo R. Gomez P05.171 RLS in Women: Gender Differences in Northeastern Sicily Rosalia Silvestri, Irene Aricò, Giuseppe Gervasi, Rosaria Condurso, Giuseppe Mento RESTLESS LEGS SYNDROME AND FIBROMYALGIA P05.172 Pramipexole for Restless Legs Syndrome and Associated Sleep Disturbance Luigi Ferini-Strambi, Dagfinn Aarskog, Ray Chaudhuri, Markku Partinen, Mandy Sohr, Daniela Verri P05.173 Pramipexole for the Treatment of RLS and Associated Depressive Symptoms Pasquale Montagna, Magdolna Hornyak, Jan Ulfberg, Seung Hong, Juergen Koester, Giovanna Crespi P05.174 Restless Legs Syndrome and Periodic Leg Movement Disorder Following Multiple Blood Donations Krishna Mettu, Sangeeta Rajashekhara, Manjamalai Sivaraman, Pradeep Sahota P05.175 Pramipexole Improves Restless Legs Syndrome in a Pediatric Patient Marcel Hungs, Harold Smith P05.176 Clinical Pharmacokinetic Drug-Interaction Studies of XP13512, a Novel Transported Prodrug of Gabapentin, with Naproxen and Cimetidine Ritu Lal, Juthamas Sukbuntherng, Wendy Luo, Paula G. Elster, Judy Ho, Robin L. Blumenthal, Kenneth C. Cundy P05.177 Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin, at Supratherapeutic Doses Ritu Lal, Juthamas Sukbuntherng, Wendy Luo, Dan Chen, Amanda Vu, Kenneth Cundy P05.178 Pregabalin Treatment Effects: Correlations of Sleep Diaries with Medical Outcomes Sleep Scale (MOSSS) in Fibromyalgia (FM) Patients in Two Studies Jeannette Barrett, Irwin Russell, Lynne Pauer, Ed Whalen NEURO-ONCOLOGY II P05.179 Phase I/Pharmacokinetic Study of Enzastaurin Plus Temozolomide during and Following Radiation Therapy in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM) or Gliosarcoma (GS) Nicholas Butowski, Kathleen Lamborn, Susan Chang, Rebecca DeBoer, Margaretta Page, Jane Rabbitt, Ann Fedoroff, Rupa Parvataneni, Valene Kivett, Steven J. Nicol, Luna Musib, Astra Leipa, Donald Thornton, Michael Prados P05.180 A Phase Ib Study of AdVtk + Valacyclovir Gene Therapy in Combination with Standard Radiation Therapy for Patients with Malignant Glioma Pamela Z. New, David Baskin, Todd Trask, Kimbra Harris, Estuardo Aguilar-Cordova, Laura Aguilar, Robert M. Cavaliere, Susan Bell, Atom Sarkar, John McGregor, Antonio Chiocca P05.181 Epilepsy and Brain Tumors: Frequency and Medical Therapy Melanie S. Van Breemen, Lynn M. Rysman, Erik B. Wilms, Rob Walchenbach, Martin J. Taphoorn, Charles J. Vecht P05.182 The Role of Surgical Resection for Seizure Control in Primary and Metastatic Brain Tumors: A Retrospective Study Jennifer M. Connelly, Mark Malkin, Hendrikus Krouwer, Wade Mueller, Romila Mushtaq P05.183 Bevacizumab in Recurrent Glioblastoma Multiforme Tania Tayah, Georges Y. Chahine, Francois G. Kamar P05.184 Bevacizumab Appears Active Against Recurrent Glioblastoma Multiforme: A Case Series Ahmed Hassan, Hassan M. Fathallah-Shaykh P05.185 Asian Patients with Glioblastoma Siew-ju See, Eu Tiong Chua, Keith Lim, Lily Tay, Meng Wong P05.186 Survival of Patients with Glioblastoma Multiforme at Hartford Hospital: Ten Years Experience Alexandra Flowers P05.187 Anaplastic Oligodendroglioma in Turcot Syndrome: Molecular Analysis and Review of the Literature Joachim M. Baehring, Serguei I. Bannykh P05.188 Ewing's Sarcoma Family Tumors Mimicking Primary Central Nervous System Neoplasms Brett J. Theeler, Joren B. Keylock, Matthew C. Kidd, Brett A. Schlifka P05.189 CSF Study in Paraneoplastic Syndromes Dimitri Psimaras, Antoine Carpentier, PNS Euronetwork P05.190 Uptake of Anti-Yo Antibody Is Followed by Purkinje Cell Death in Organotypic Cultures: Implications for the Pathogenesis of Paraneoplastic Cerebellar Degeneration John E. Greenlee, Susan A. Clawson, Kenneth E. Hill, Noel G. Carlson P05.191 Immunomediated Limbic Encephalitis: Clinical and Immunological Description of 15 Patients Roberta Vitaliani, Marco Zoccarato, Luigi Zuliani, Vincenza Argentiero, Bruno Giometto P05.192 Do Blood-Brain Barrier Breakdown Serum Markers Have Clinical Significance in Patients with Onconeuronal Antibodies? Slawomir Michalak, Mieczystaw Wender, Grazyna Michalowska-Wender, Wojciech Kozubski P05.193 Epidemiology, Neurological Phenotypes and Tumour Associations in a Series of 51 Non-Selected Patients with Serologically Confirmed Diagnosis of Paraneoplastic Neurological Syndrome Anna Czlonkowska, Grazyna Gromadzka, Zofia Lysiak, Anna Sliwinska P05.194 The Effects of Cerebellar Degeneration on Spatial Orientation Disturbances in Rats with Experimental Neoplastic Disease Michal Szulc, Slawomir Michalak, Andrzej Rybarczyk, Wojciech Kozubski P05.195 Reversible Posterior Leukoencephalopathy Syndrome Following the Administration of Bevacizumab for Colon Cancer Metastatic to the Liver Wael Richeh, Jean François Chermann, Carole Sereni P05.196 WITHDRAWN

POSTER SESSION V

MIGRAINE, PFO, VESTIBULAR P05.197 Role of Greater Occipital Nerve Injections for Patients with Dizziness and Headache Eric Baron, Neil Cherian P05.198 Follow Up Investigation of Balance in Migraineurs Gulden Akdal, Birgul Donmez, Vesile Ozturk P05.199 Clinical Features and Disability of Migraine and Probable Migraine by Age Uri Napchan, Richard B. Lipton, Brian Grosberg, Michael Reed, Daniel Serrano, Juline M. Bryson, Marcelo E. Bigal P05.200 Familial Clustering of Migraine and Patent Foramen Ovale: Pilot Study and Genetic Perspectives in a Population Isolate Maurizio Facheris, Agatha Eisendle, Daniela Grazio, Irene Pichler, Helmuth Weiss, Hugo Daniel, Herman Zingerle, Angelika Kaneppele, Giuseppe Roscia, Ingrid Stockner, Gabriele Sixt, Rudolf Schoenhuber, Andrew A. Hicks, Peter Pramstaller

69

Information

untitled

5 pages

Find more like this

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate

76370


You might also be interested in

BETA
untitled